Dr. Michael Matthay was an undergraduate student at Harvard University and a medical student at the University of Pennsylvania School of Medicine. He completed his training in Internal Medicine at the University of Colorado and in Pulmonary/Critical Care Medicine at UCSF.
Currently, Matthay is a Professor of Medicine and Anesthesia at the University of California, San Francisco and a Senior Associate in the Cardiovascular Research Institute. His research probes the pathophysiology of acute lung injury and pulmonary edema. Matthay has published over 500 research papers, and has had numerous NIH grants over his career. He currently has Investigational New Drug (IND) approval from the Food and Drug Administration for studies of mesenchymal stem cells as a treatment for Acute Respiratory Distress Syndrome.
